XBiotech Inc.

4.44-0.0600-1.33%Vol 14.73K1Y Perf -56.27%
Jan 27th, 2023 16:00 DELAYED
BID4.00 ASK4.59
Open4.55 Previous Close4.50
Pre-Market- After-Market4.59
 - -  0.15 3.38%
Target Price
18.00 
Analyst Rating
— 0.00
Potential %
305.41 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-/-/-100 
Value Ranking
★★★+     54.47
Insiders Value % 3/6/12 mo.
-/-/-100 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12 mo.
-/-/-100 
Income Ranking
 —    -
Price Range Ratio 52W %
17.69 
Earnings Rating
Neutral
Market Cap135.15M 
Earnings Date
21st Mar 2023
Alpha0.01 Standard Deviation0.19
Beta1.35 

Today's Price Range

4.374.55

52W Range

3.0011.14

5 Year PE Ratio Range

-27.401.80

Summary:

Buy

Technical Indicators: Buy
Moving Averages: Strong Buy
Performance
1 Week
5.71%
1 Month
41.40%
3 Months
24.72%
6 Months
-13.79%
1 Year
-56.27%
3 Years
-80.75%
5 Years
-6.13%
10 Years
-

TickerPriceChg.Chg.%
XBIT4.44-0.0600-1.33
AAPL145.931.97001.37
GOOG100.711.55001.56
MSFT248.150.15000.06
XOM115.61-2.1500-1.83
WFC46.120.31000.68
JNJ168.23-0.6600-0.39
FB196.640.99000.51
GE83.232.09002.58
JPM140.320.34000.24
 
ProfitabilityValueIndustryS&P 500US Markets
79.50
-408.30
-373.30
-
-94.71
RevenueValueIndustryS&P 500US Markets
3.71M
0.12
-
-
Earnings HistoryEstimateReportedSurprise %
Q03 2022--0.42-
Q02 2022--0.38-
Q03 2021--0.11-
Q02 2021--0.17-
Q01 2021--0.09-
Q02 2020--0.24-
Q01 20200.060.00-100.00
Q02 2019-0.15-0.16-6.67
Earnings Per EndEstimateRevision %Trend
6/2020 QR0.04-33.33Negative
9/2020 QR0.04-33.33Negative
12/2020 FY0.19-17.39Negative
12/2021 FY0.13-35.00Negative
Next Report Date21st Mar 2023
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume14.73K
Shares Outstanding30.44K
Shares Float23.59M
Trades Count162
Dollar Volume65.74K
Avg. Volume35.93K
Avg. Weekly Volume32.80K
Avg. Monthly Volume37.28K
Avg. Quarterly Volume37.69K

XBiotech Inc. (NASDAQ: XBIT) stock closed at 4.44 per share at the end of the most recent trading day (a -1.33% change compared to the prior day closing price) with a volume of 14.73K shares and market capitalization of 135.15M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 89 people. XBiotech Inc. CEO is John Simard.

The one-year performance of XBiotech Inc. stock is -56.27%, while year-to-date (YTD) performance is 26.5%. XBIT stock has a five-year performance of -6.13%. Its 52-week range is between 3 and 11.14, which gives XBIT stock a 52-week price range ratio of 17.69%

XBiotech Inc. currently has a PE ratio of -3.00, a price-to-book (PB) ratio of 0.45, a price-to-sale (PS) ratio of 30.60, a price to cashflow ratio of 2.50, a PEG ratio of 2.32, a ROA of -14.83%, a ROC of -14.46% and a ROE of -15.16%. The company’s profit margin is -94.71%, its EBITDA margin is -373.30%, and its revenue ttm is $3.71 Million , which makes it $0.12 revenue per share.

Of the last four earnings reports from XBiotech Inc., there were 0 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.00 for the next earnings report. XBiotech Inc.’s next earnings report date is 21st Mar 2023.

The consensus rating of Wall Street analysts for XBiotech Inc. is (0), with a target price of $18, which is +305.41% compared to the current price. The earnings rating for XBiotech Inc. stock is Neutral (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

XBiotech Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

XBiotech Inc. has a Buy technical analysis rating based on Technical Indicators (ADX : 8.96, ATR14 : 0.26, CCI20 : 68.19, Chaikin Money Flow : 0.18, MACD : 0.27, Money Flow Index : 71.03, ROC : 16.84, RSI : 64.08, STOCH (14,3) : 70.25, STOCH RSI : 0.70, UO : 51.23, Williams %R : -29.75), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of XBiotech Inc. in the last 12-months were:

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0
0
1 (100.00 %)
Moderate Buy
0
0
0 (0.00 %)
Hold
0
0
0 (0.00 %)
Moderate Sell
0
0
0 (0.00 %)
Strong Sell
0
0
0 (0.00 %)
Summary Rating-
0.00
-
0.00
Strong Buy
1.00

XBiotech Inc.

XBiotech Inc is a US-based clinical-stage biopharmaceutical company. It is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing MABp1 a therapeutic antibody as a treatment for cancer. Geographically, all of its operations are in the United States.

CEO: John Simard

Telephone: +1 512 386-2900

Address: 5217 Winnebago Lane, Austin 78744, TX, US

Number of employees: 89

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

43%57%

Bearish Bullish

50%50%

Bearish Bullish

51%49%


News

Stocktwits